HeMo Bioengineering Pte. Ltd.
HeMo Bioengineering Pte. Ltd., commonly referred to as HeMo Corp, is a pioneering company headquartered in Singapore (SG) that operates at the forefront of the bioengineering industry. Founded in 2015, HeMo has rapidly established itself as a leader in developing innovative biotechnological solutions, particularly in the fields of regenerative medicine and tissue engineering. With a strong focus on creating advanced biomaterials and cellular therapies, HeMo's core products are distinguished by their unique ability to enhance healing processes and improve patient outcomes. The company has achieved significant milestones, including collaborations with leading research institutions and successful product launches that have garnered attention in the global market. HeMo Bioengineering continues to solidify its position as a key player in the bioengineering sector, committed to advancing healthcare through cutting-edge technology and research.
DitchCarbon Score
How does HeMo Bioengineering Pte. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HeMo Bioengineering Pte. Ltd.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HeMo Bioengineering Pte. Ltd.'s reported carbon emissions
HeMo Bioengineering Pte. Ltd., headquartered in Singapore (SG), currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the context of the bioengineering industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While HeMo Bioengineering has not yet established specific targets or initiatives, the industry as a whole is moving towards more sustainable practices and commitments to mitigate climate impacts. As the company progresses, it may consider adopting industry-standard climate strategies, such as setting Science-Based Targets (SBTs) or participating in climate pledges to enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HeMo Bioengineering Pte. Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
